MATARACI KARA, E. Et Al. 2020. Evaluation of the synergy of ceftazidime/avibactam in combination with colistin, doripenem, levofloxacin, tigecycline, and tobramycin against OXA-48 producing Enterobacterales. Journal of Chemotherapy , vol.32, no.4 , 171-178.

MATARACI KARA, E., Yilmaz, M., Istanbullu Tosun, A., & ÖZBEK ÇELİK, B., (2020). Evaluation of the synergy of ceftazidime/avibactam in combination with colistin, doripenem, levofloxacin, tigecycline, and tobramycin against OXA-48 producing Enterobacterales. Journal of Chemotherapy , vol.32, no.4, 171-178.

MATARACI KARA, Emel Et Al. "Evaluation of the synergy of ceftazidime/avibactam in combination with colistin, doripenem, levofloxacin, tigecycline, and tobramycin against OXA-48 producing Enterobacterales," Journal of Chemotherapy , vol.32, no.4, 171-178, 2020

MATARACI KARA, Emel M. Et Al. "Evaluation of the synergy of ceftazidime/avibactam in combination with colistin, doripenem, levofloxacin, tigecycline, and tobramycin against OXA-48 producing Enterobacterales." Journal of Chemotherapy , vol.32, no.4, pp.171-178, 2020

MATARACI KARA, E. Et Al. (2020) . "Evaluation of the synergy of ceftazidime/avibactam in combination with colistin, doripenem, levofloxacin, tigecycline, and tobramycin against OXA-48 producing Enterobacterales." Journal of Chemotherapy , vol.32, no.4, pp.171-178.

@article{article, author={Emel MATARACI KARA Et Al. }, title={Evaluation of the synergy of ceftazidime/avibactam in combination with colistin, doripenem, levofloxacin, tigecycline, and tobramycin against OXA-48 producing Enterobacterales}, journal={Journal of Chemotherapy}, year=2020, pages={171-178} }